Getz Pharma, BIDE & SZABIST join hands to foster a culture of collaboration to improve healthcare indicators in Pakistan KARACHI ( Web News ) Pakistan is facing a steep rise in the prevalence of non-communicable diseases (NCD). Recent figures from IDF Atlas are staggering depicting a sharp increase in diabetes.Read More →

Getz Pharma launches ‘ MEDACE’ , online learning platform for medical professional Getz Pharma, in collaboration with Dow University of Health Sciences (DUHS), has announced the launch of the first three courses on their brand new online medical learning platform MEDACE. KARACHI ( Web News ) ‘MEDACE’ is an initiativeRead More →

LAHORE ( Web News ) An MoU signing ceremony for Neurology Research Grants (NRG) was held last Friday, between Pakistan Society of Neurology (PSN), Dow University of Health Sciences (DUHS), and Getz Pharma at their head office.  Strict compliance with COVID 19 safety guidelines was observed. Prof. Saleem Barech, PresidentRead More →

LAHORE ( Web News ) As a research-driven pharmaceutical company, Getz Pharma takes an active role in supporting advanced scientific studies that can help patients and healthcare professionals in dealing with life-threatening diseases. This time, Getz Pharma is proud to launch Pakistan’s First Metabesity Guideline in collaboration with leading medicalRead More →

KARACHI (PRESS RELEASE) Getz Pharma and Tabba Heart Institute, in order to address the issue of the rising health burden of ASCVD in Pakistan are entering into a Joint Venture Agreement for the largest, first-of-its-kind, longitudinal cohort study on Atherosclerotic Risk Assessment in Pakistani Population. This study aims to recruitRead More →